DHF, R., TD, M., & YH, G. (2023). Neisseria gonorrhoeae ciprofloxacin susceptibility testing and gyrA targets - Authors' reply. The Lancet. Microbe, 4(8), e575. https://doi.org/10.1016/S2666-5247(23)00150-7
Chicago Style (17th ed.) CitationDHF, Rubin, Mortimer TD, and Grad YH. "Neisseria Gonorrhoeae Ciprofloxacin Susceptibility Testing and GyrA Targets - Authors' Reply." The Lancet. Microbe 4, no. 8 (2023): e575. https://doi.org/10.1016/S2666-5247(23)00150-7.
MLA (9th ed.) CitationDHF, Rubin, et al. "Neisseria Gonorrhoeae Ciprofloxacin Susceptibility Testing and GyrA Targets - Authors' Reply." The Lancet. Microbe, vol. 4, no. 8, 2023, p. e575, https://doi.org/10.1016/S2666-5247(23)00150-7.
Warning: These citations may not always be 100% accurate.